/Labcorp%20Holdings%20Inc_%20logo%20magnified-by%20ll_studio%20via%20Shutterstock.jpg)
Burlington, North Carolina-based Labcorp Holdings Inc. (LH) is a provider of laboratory services. It offers various tests, such as blood chemistry analyses, urinalyses, thyroid, PAP, substance abuse, and many more. With a market cap of $19.4 billion, Labcorp Holdings operates through Diagnostics Laboratories and Biopharma Laboratory Services segments.
Shares of the medical laboratory operator have underperformed the broader market over the past year. Over the past 52 weeks, LH stock has gained 8.5%, lagging behind the S&P 500 Index’s ($SPX) 27.5% returns. In 2024, LH is up 1.3% compared to SPX’s 17.8% gains on a YTD basis.